A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome-Reference-Cited by-同舟云学术

A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome

Published:2014 Issue:1 Volume:5 Page:54
ISSN:2040-2392
Container-title:Molecular Autism
language:en
Short-container-title:Molecular Autism

Author:

Kolevzon Alexander,Bush Lauren,Wang A,Halpern Danielle,Frank Yitzchak,Grodberg David,Rapaport Robert,Tavassoli Teresa,Chaplin William,Soorya Latha,Buxbaum Joseph D

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Developmental Biology,Developmental Neuroscience,Molecular Biology

Reference28 articles.

1. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

2. Novel de novo SHANK3 mutation in autistic patients

3. Structural Variation of Chromosomes in Autism Spectrum Disorder

4. Contribution of SHANK3 Mutations to Autism Spectrum Disorder

5. The postsynaptic density

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-Like Growth Factor 1 Has the Potential to Be Used as a Diagnostic Tool and Treatment Target for Autism Spectrum Disorders;Cureus;2024-07-25

2. Long-term treatment with insulin-like growth factor-1 in Phelan-McDermid syndrome: a case report;Rare Disease and Orphan Drugs Journal;2024-05-06

3. Caregiver perspectives on patient-focused drug development for Phelan-McDermid syndrome;Orphanet Journal of Rare Diseases;2024-03-26

4. Association between serum insulin-like growth factor 1 levels and the improvements of cognitive impairments in a subgroup of schizophrenia: Preliminary findings;Schizophrenia Research;2024-02

5. A role for astrocytic insulin-like growth factor I receptors in the response to ischemic insult;Journal of Cerebral Blood Flow & Metabolism;2023-11-28